The same authors were also involved a case study where the uptake of [6-O-methyl-11C]erlotinib corresponded to metastatic lesions in the brain of a NSCLC patient with an EGFR Del19 mutated lung tumor [104]. Here, EGFR is linked to non-small cell lung carcinoma.